...
【24h】

Bilateral reversible corneal edema associated with amantadine use.

机译:与金刚烷胺使用相关的双侧可逆性角膜水肿。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: In this article, we report a case of bilateral severe reversible corneal edema caused by amantadine therapy. CASE: A 39-year-old women was referred to us for evaluation of bilateral corneal edema. Her past medical history was significant for multiple sclerosis, anorexia, and seizures. She developed painless progressive bilateral loss of vision for the past 6 months. She was evaluated by several ophthalmologists elsewhere who felt that the patient's visual loss was secondary to a nutritional deficiency as opposed to related to multiple sclerosis. She was started on vitamin B-12 medication without improvement in her symptoms. She was then evaluated by neuro-ophthalmology. The examination revealed severe bilateral corneal edema and was referred to our corneal service for further evaluation of her corneal condition. Our examination revealed best corrected visual acuity of 20/400 bilaterally. Corneal thickness was 940 microm in the right eye and 802 microm in the left. Color vision was intact. Conjunctivas were white bilaterally. Cornea evaluation revealed diffuse stromal edema and Descemet's folds and microcystic subepithelial edema with to guttae noted. Anterior chambers were deep and quiet. A specular microscopy revealed significant pleomorphism and polymegathism with an endothelial cell count of 1,504 cells in the right eye and 1,596 in the left eye. RESULTS: Review of the patient's medical information revealed therapy with amantadine 2 months prior to the appearance of the patient's symptoms as a means to control the patient's tremors. The patient experienced rapid resolution of the corneal edema within the next 2 months after discontinuation of the agent with recovery of best corrected visual acuity of 20/40 in the right eye and 20/30 in the left. CONCLUSIONS: In cases of unexplained corneal edema and in the absence of any identifiable ocular cause, a review of toxic effects of systemic medications should be performed. Early diagnosis may prevent irreversible endothelial damage. Amantadine can cause endothelial failure and needs to be considered as part of the differential diagnosis of corneal edema.
机译:目的:在本文中,我们报告了一例由金刚烷胺治疗引起的双侧严重可逆性角膜水肿的病例。案例:一位39岁的妇女被转介给我们评估双侧角膜浮肿。她过去的病史对多发性硬化症,厌食症和癫痫病具有重要意义。在过去的六个月中,她出现了无痛性进行性双侧视力丧失。其他地方的几位眼科医生对她进行了评估,他们认为患者的视力丧失是营养缺乏所致,而不是多发性硬化症。她开始服用维生素B-12药物,但症状没有改善。然后通过神经眼科对她进行评估。检查发现双侧严重角膜水肿,并转诊给我们的角膜服务处以进一步评估她的角膜状况。我们的检查显示双侧最佳矫正视力为20/400。右眼的角膜厚度为940微米,而左眼的厚度为802微米。色觉完好无损。结膜双侧呈白色。角膜评估显示弥漫性基质水肿和Descemet褶皱以及微囊性上皮下水肿,并伴有牙胶。前房深而安静。镜检显微镜显示显着的多态性和多角体病,右眼的内皮细胞计数为1,504个细胞,左眼的内皮细胞计数为1,596个。结果:对患者的医疗信息的审查显示,在患者出现症状前2个月使用金刚烷胺进行治疗,以控制患者的震颤。停药后的两个月内,患者经历了角膜水肿的快速消退,右眼的最佳矫正视力恢复到右眼20/40,左眼的矫正视力恢复到20/30。结论:在无法解释的角膜水肿的情况下,并且在没有任何可确定的眼病原因的情况下,应该对全身药物的毒性作用进行评估。早期诊断可以预防不可逆的内皮损伤。金刚烷胺可引起内皮功能衰竭,需要作为角膜水肿鉴别诊断的一部分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号